The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2.
CNN.com - RSS Channel - Health, CNN: Health
Fri, 05/24/2019 - 11:12am
The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2.